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Abstract
Introduction: Sinonasal polyposis (NP) is a chronic inflammatory pathology of the nasal/para-
nasal cavities which affects from 1%-4% of the population. Although polyps seem to be a man-
ifestation of chronic inflammation in both allergic and non-allergic subjects, the pathogenesis 
of nasal polyposis remains unknown. HLA-G molecules are a kind of no classic class I antigen 
with anti-inflammatory and tolerogenic properties. Little attention has been paid to the role of 
HLA-G chronic inflammatory disorders. 
Objective: The aim of this study is to investigate the expression of HLA-G in the NP. 
Materials and methods: Prospective study involving samples of patients presenting with nasal pol-
yposis that were subjected to the immunohistochemistry technique. After a skin prick test, all pa-
tients were divided into atopic and nonatopic groups and classified as asthmatic or non-asthmatic. 
Results: Immunohistochemical staining demonstrated a higher expression of the HLA-G mole-
cule in samples from nonatopic than in those from atopic patients, and was significantly lower 
in the non-asthmatic patients. 
Conclusion: These results indicate that HLA-G may play an important role in the pathology of 
nasal polyposis. Considering the anti-inflammatory properties of HLA-G, this study suggests that 
it could reduce susceptibility to atopy and asthma.
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier 
Editora Ltda. All rights reserved.
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A expressão do antígeno humano leucocitário G (HLA-G) em pacientes com polipose nasossinusal 
Resumo
Introdução: Polipose nasossinusal (PNS) é uma patologia inflamatória crônica das cavidades 
nasais/paranasais que afeta 1%-4% da população. Embora os pólipos pareçam ser uma manifes-
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Introduction
Sinonasal polyposis (NP) or chronic rhinosinusitis with na-
sal polyps is a chronic inflammatory pathology of the nasal 
and paranasal cavities,1,2 which affects from one to four 
per cent of the population and has a clear association with 
asthma, aspirin sensitivity and cystic fibrosis.3 
Patients with NP typically present with nasal obstruc-
tion, rhinorrhea, hyposmia and reduced quality of life.3,4 
Although polyps seem to be a manifestation of the chronic 
inflammation of nasal/paranasal sinus mucosa in both al-
lergic and non-allergic subjects, the pathogenesis of nasal 
polyposis remains unknown,5,6 but it is probably a multi-
factorial disease with several different etiological factors, 
and chronic persistent inflammation is undoubtedly a major 
factor irrespective of the etiology.5 Chronic inflammation of 
the mucous represents a challenge for the otolaryngologist.
The diagnosis of NP is confirmed by nasal endoscopy or a 
computed tomography (CT) scan.1 Despite the major impact 
on quality of life,7 in the literature little attention has been 
paid to the biomarkers involved in the pathogenesis of nasal 
polyps and their possible contributions to the prognosis of NP.
The HLA-G is a nonclassical MHC class I molecule char-
acterized by its restricted expression in tissues (cytotropho-
blast, amnion epithelial cells of the thymus, pancreas, and 
in the proximal nail matrix), its low polymorphism as well as 
its seven isoforms (HLA G1 -G7).8,9 The expression of HLA-G 
is induced by interleukin-10 or gamma interferon and ex-
erts a negative immunoregulatory effect by inhibiting the 
proliferation of allogeneic T cells, natural killer cells and 
antigen-specific cytotoxic T cells. Because of its effects on 
the immune system, this expression can have beneficial as 
well as harmful consequences for the organism.9,10 
Little attention has been paid to the role of HLA-G in au-
toimmune and chronic inflammatory disorders, but evidence 
shows that the expression of HLA-G in inflammatory skin dis-
eases including psoriasis and atopic dermatitis11 is associated 
with a better clinical course of the disease.3,9 Another study 
suggests that serum HLA-G might be considered a biomarker 
for atopic asthmatic patients.12 In cancer, HLA-G expression 
has been associated with metastasis development.13 
Considering this lack of understanding of the mechanism 
which triggers inflammation and which hinders the devel-
opment of new treatments for this disease, and the impor-
tance of the characterization of inflammatory mediators in-
volved in the pathogenesis of NP, the objective of this study 
was to investigate the HLA-G expression in NP in atopic and 
non-atopic patients. There are no studies about the HLA-G 
in situ expression in the NP lesions.
Methods
Study population
This was a historical cohort with cross-sectional study in 
which twenty-five patients, who presented with sinosanal 
polyposis and who had been submitted to surgery for polyp 
resection, were evaluated. We also evaluated five normal 
mucosa samples from the middle meatus of patients without 
symptoms of atopy that were submitted to rhinoseptoplas-
ty. All patients underwent clinical otorhinolaryngologic 
evaluation with a nasal endoscopy, computed tomography 
(CT) scan, lung function test (spirometry) and the skin prick 
test before surgery. The preoperative CT scans were gra-
ded according to the Kennedy classification, to evaluate the 
extent of patients with NP,10 and all were investigated for 
allergy and positive history for asthma. They were divided in 
two groups: atopic (positive skin prick test) and non-atopic 
patients (negative skin prick test). The skin prick test was 
performed with 10 extracts: histamine (positive control), 
saline solution (negative control), D. pteronyssinus, D. fari-
nae, Blomia tropicalis, Felix domesticus, Canis familiars, P. 
Americana, Aspergillus fumigatus and Alternaria alternate. 
The response was considered positive when there was a halo 
of 3 mm larger than that of the negative control.
The NP patients were classified as having positive or nega-
tive history for asthma, which was confirmed by spirometry. This 
study was approved by the Research Ethics Committee under 
the protocol 0711/11 and approved in 06/02/11. All patients 
signed a term of informed consent for participation in the study. 
The financial support of this study was National Counsel of Tech-
nological and Scientific Development (CNPq) and Foundation for 
Research Support of the State of Goiás (FAPEG).
tação de inflamação crônica em ambos os indivíduos alérgicos e não alérgicos, a patogênese da 
polipose nasal permanece desconhecida. Moléculas HLA-G são antígenos não clássicos da classe 
I com propriedades anti-inflamatórias e tolerogênicas. Pouca atenção tem sido dada ao papel 
do HLA-G em doenças inflamatórias crônicas. 
Objetivo: Investigar a expressão de HLA-G na PNS. 
Materiais e métodos: Estudo prospectivo de pacientes com polipose nasal que foram submeti-
das à técnica de imuno-histoquímica. Após realizarem teste cutâneo, os pacientes foram dividi-
dos em grupos atópicos e não atópicos e classificados como asmáticos ou não asmáticos. 
Resultado: A coloração imuno-histoquímica mostrou uma maior expressão da molécula HLA-G 
em pacientes não atópicos do que naqueles atópicos e foi significativamente inferior nos pa-
cientes não asmáticos. 
Conclusão: Os resultados indicam que o HLA-G pode ter um papel importante na patologia da 
polipose nasal. Considerando as propriedades anti-inflamatórias do HLA-G, este estudo sugere 
que ele poderia reduzir a susceptibilidade a atopia e asma.
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Publicado por Elsevier 
Editora Ltda. Todos os direitos reservados.
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Immunohistochemistry
After resection surgery, the polyps were subjected to the 
immunohistochemistry technique. Four-micrometer sec-
tions were cut from paraffin-embedded specimens. The 
Universal HRP-Polymer MACH 4 detection system (Biocare 
Medical, Concord, CA, USA) was used. In summary, after 
rinsing the sections in phosphate buffered saline with 0.1% 
saponin, endogenous peroxidases were inhibited using 
H2O2. Samples were initially incubated with specific or ir-
relevant antibodies for 1 hour at room temperature and 
subsequently with a solution containing a MACH 4 Mouse 
Probe for 15 minutes. Diaminobenzidine plus a chromogen-
substrate was used to develop antibody fixation. The spe-
cific monoclonal antibodies MEM-G/2 (Exbio, Prague, Cze-
ch Republic) recognize the free heavy-chain of all HLA-G 
isoforms. An identical IgG1 isotype anti-desmin antibody 
which was run simultaneously with each sample served as 
a negative control.
Evaluation of stained sections
The paraffin-embedded polyp specimens were stained with 
haematoxylin-eosin-safranin for histological examination. 
The percentage of eosinophilic inflammatory infiltrate was 
scored as follows: 0, no inflammatory cells; 1, < 25% in-
flammatory cells; and 2, ≥ 25% inflammatory cells. 
The immunohistochemical analysis was carried out 
on polyp tissue. Immunoreactivity was scored using a 
semi-quantitative scoring method by evaluating the per-
centage of positive cells. The cut-off scores for determining 
the positivity of HLA-G detected by immunohistochemis-
try were obtained by the receiver operating characteristic 
(ROC) curve analysis. ROC curve analysis was performed for 
HLA-G expression. This was the first study to demonstrate 
the expression of HLA-G in polyposis nasinusal. There are 
no references in the specialized literature about the val-
ue to be considered as positive and negative in ROC curve. 
However, as is well established in studies on various types 
of cancers, any rate of expression of this molecule has con-
sequences in the tumor microenvironment, inducing immu-
nomodulation. Our goal was to calculate the ROC curve, so 
we used standard statistical test to establish the cut-off 
to produce greater sensitivity and specificity, although we 
know that even an expression less than 20% of cells has the 
potential to provide immunomodulatory effects.
All sections were blindly analyzed using a light microscope 
with high-power fields (×400). Ten random fields were chosen. 
Labeling of cells and other structures, as well as some of the 
epithelial cells and inflammatory cells were not observed. It 
was considered, to establish the percentage of positive cells, 
the average HLA-G positive cells among the total epithelial 
cells per field. The average HLAG positive cells in the ten fields 
analyzed was calculated to obtain the final value.
Statistical analysis
The ROC curve of staining performance for the determi-
nation of HLA-G cut-off expression was performed. The 
immunostaining scores were compared to the Mann–Whit-
ney U test, and the correlations of the immunostaining 
scores were tested with Spearman correlation analysis. 
Comparative analysis between the groups were perfor-
med by the two-sided Fisher exact test. A p-value of 
less than 0.05 was considered significant. All statisti-
cal analysis were performed using the GraphPad Instat 
(version 5.0).
Results
Clinical and epidemiological findings
The results included 25 patients with sinonasal polyposis 
submitted to nasal endoscopy and CT scan to confirm the 
disease. The patient group consisted of 13 (52%) males and 
12 (48%) females aged between 35 and 83 (mean: 48.8 ye-
ars). The patients are divided into two groups: the group 
with a negative prick test (non-atopic group) consisted of 13 
patients and the other group consisted of 12 patients with 
positive prick test (atopic group). Among these patients, 17 
presented asthma.
Using CT-scan evaluation, patients were classified 
according to the criteria described in Kennedy et al. to 
evaluate the extent of NP. Most patients were classified 
as grade II.
The expression of HLA-G
Following histological examination, HLA-G staining was ob-
served in epithelial and inflammatory cells in NP samples 
(Fig. 1). HLA-G was not seen in normal mucosa samples.
On ROC curve analysis, the cut-off for positive re-
sults was 20% or greater (AUC = 0,750; p = 0,011; 95% 
CI 0,516 to 0,910). Considering that, HLA-G molecules 
could be detected in 9 out the 25 specimens evaluated 
(36%). 
HLA-G expression in NP specimens was associated with 
atopy, asthma and the presence of eosinophilia on polyps. 
Immunohistochemical staining demonstrated a high-
er expression of HLA-G molecule in samples of non-atopic 
patients when compared with atopic patients (p = 0.028). 
It was observed that among the HLA-G positive specimens, 
only 2 patients presented atopy (p = 0.0154; RR = 0.2727; 
95% CI, 0.07606 to 0.9779). 
The HLA-G expression was significantly higher in the 
group of non-asthmatic patients (p = 0,005, and 95% CI 
0,01304 to 0,6791). Only 1 of the 9 HLA-G + patients pre-
sented asthma.
The patients whose prick test was positive had lower 
percentage of HLA-G positive cells when compared with pa-
tients whose prick test was negative (p = 0.03) (Fig. 2).
Finally, comparing the expression of HLA-G with eosino-
philia found in SN, we observed that HLA-G positive patients 
presented lower eosinophilia (Fig. 3).
Discussion
NP is a chronic inflammatory condition associated with 
substantial impaired quality of life, reduced workplace 
productivity, and considerable medical treatment costs.7,14 
Despite recent research evidence contributing to further 
The HLA-G expression in patients with nasal polyposis 211
comprehension of the pathophysiology of this chronic ai-
rway condition, the pathogenesis of SNP remains poorly un-
derstood and appears to be multifactorial, being associated 
with conditions such as atopy, asthma, cystic fibrosis, aspi-
rin sensitivity and chronic rhinosinusitis.15-17
A diverse spectrum of alterations involving T-cell pat-
terns, cytokine profiles, IgE production, microorganisms and 
immune system malfunctions should be associated with NP 
pathogenesis.9,10 In this context, this study evaluated the 
HLA-G expression in NP lesions for the first time.
This analysis showed that the HLA-G was expressed in 9 
patients with NP. There was no HLA-G expression in normal 
mucosa. Interestingly, the HLA-G expression tended to be 
significantly more frequent in patients with negative prick 
test, or in other words, non-atopic patients (p = 0.028). In 
contrast to these results, Ciprandi et al. showed that serum 
HLA-G (s-HLA-G) molecules are significantly increased in al-
lergic rhinitis, but they conducted their study with allergic 
adults and children without polyposis, and worked with the 
serum expression.18,19 More recently, HLA-G has again been 
shown to have increased expression in several immunolog-
ical diseases including asthma and allergic rhinitis.20 Based 
on the contrasting results of this study, it can be speculated 
that the expression of HLA-G in NP may contribute to de-
creased susceptibility to atopy in NP, a factor which aggra-
vates the disease. 
A significant association between HLA-G expression and 
the absence of asthma was also seen, which could reinforce 
the thesis that the presence of this HLA-G could be a marker 
for a better prognosis of SNP. Although it has been hypoth-
esized that HLA-G is associated with the pathogenesis of 
asthma, these results remain controversial. Zhen et al. have 
suggested that sHLA-G might be considered as a biomark-
er for atopic asthmatic patients, and have shown that an 
increase of sHLA-G with decreased IL-10 levels may have 
implications for the pathogenesis of atopic asthma.20,21 
But the authors of this study saw that non-asthmatic and 
non-atopic patients presented a significantly higher expres-
sion of HLA-G. It must be considered that the groups were 
very different, because all the patients in this study had 
SNP, and the presence of atopy and asthma or otherwise are 
adjuvant factors which can aggravate the disease. 
A role for HLA-G in asthma pathogenesis was further sug-
gested by the demonstration of the expression of a soluble 
isoform of HLA-G, sHLA-G5, in airway epithelial cells.22 Lo-
calization of HLA-G in airway epithelium suggests that its 
deregulation could contribute to airway inflammation in 
chronic asthma. The results of this study are consistent with 
previous reports by Rizzo et al. of the defective production 
of soluble HLA-G molecules by peripheral blood monocytes 
in patients with asthma.23 HLA-G could regulate the inflam-
matory activity of inflammatory cells found in asthmatic 
airways and influence asthma susceptibility through atopic 
pathways. 
Histologically, nasal polyps can be classified into eosino-
philic and non-eosinophilic. Eosinophilic NP represents 80% 
to 90% of SNP,23,24 characterized by massive edema and the 
accumulation of eosinophils.25 The abundance of eosinophils 
in nasal polyps would seem to be explained by the increased 
migration of eosinophils into tissues and increased survival 
of these cells,26 but the pathological mechanism through 
which these eosinophils contribute to tissue damage, to the 
Figure 1 HLA-G protein detection SNP biopsies. Photomicro-
graph showing different categories of immunolabeling intensi-
ty. A, Strong staining by epithelial cells; B, Moderately and C, 
weak staining; D, Expression of HLA-G by immune-inflamma-
tory cells; E, Positive SNP patient sample to HLA-G expression 
and F, the isotype control (irrelevant antibody); G, Negative 
sample to HLA-G expression. Original magnification 10× (B,C 
and F), 20× (A) and 40× (D and G).
Figure 3 Eosinophilia and HLA-G expression. Inverse rela-
tionship between eosinophilia and expression of HLA-G. HLA-G 
positive patients presented lower eosinophilia (Mann Whitney 
test, p = 0.0330; Spearmen correlation r, p = 0.0126). 
Figure 2 HLA-G expression and Prick Test positivity. Prick Test 
positive patients presented lower percentage of HLA-G positi-
ve cells when compared with patients whose Prick test result 
was negative (p = 0.03).
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inflammatory process and the formation of polyps is not 
well understood.27 
Eosinophils may contribute to nasal polyp formation and 
growth, not only through inflammation, but also by exerting 
their effects on extracellular matrix including the stimu-
lation of collagen synthesis. In a similar vein, another in-
teresting finding of this study was the inverse relationship 
between eosinophilia and HLA-G expression.28,29 HLA-G pos-
itive polyps had a lower eosinophilia when compared with 
HLA-G negative polyps. This suggests that HLA-G has anti-in-
flammatory properties.
To sum up, this study has demonstrated, for the first 
time, the expression of HLA-G in NP. It was significantly 
higher in non-atopic and non-asthmatic patients, suggesting 
the HLA-G could inhibit the inflammatory response in NP.
Further investigations would provide deeper insights 
into the role that the HLA-G expression plays in the NP 
pathogenesis.
Conclusion
The results of this study indicated that HLA-G may play an 
important role in the pathology of sinonasal polyposis. After 
considering the anti-inflammatory properties of HLA-G, the-
se authors suggest that HLA-G could decrease susceptibility 
to atopy and asthma in NP. 
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